AstraZeneca picks Catalent for packaging potential COVID-19 vaccine

AstraZeneca Plc has struck a deal with Catalent Inc for packaging its potential COVID-19 vaccine, as the British drugmaker prepares to meet its global target of making two billion doses of the vaccine.